Stacy A. Chick

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Moving glioblastoma from terminal to treatable. Powered by patients. We collect data and help patients today and tomorrow. OurBrainBank is the first non-profit created by, with, and for people living with glioblastoma. GBM is a rare and aggressive brain cancer. The 5-year survival rate is 5%. OBB founder Jessica Morris (1963-2021) was diagnosed with GBM in 2016. Frustrated by the paucity of options, she brought together fellow patients, neuro-oncologists, and tech experts to form OBB. Our pilot study used a free app to help people manage GBM better by tracking symptoms and activities. Were now developing a new data collection program using passive data collected by everyday smartphone usage. Patient-driven data is the new currency in medical research and apps the new empowerment tool for patients. It could potentially have the same impact as a blockbuster new drug. OurBrainBank advocates for new and better treatments and improved quality of life for people living with GBM and their care partners. A key tool is our GBM Bill of Rights.

CANCER FUND Impact Investments® is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Moving glioblastoma from terminal to treatable. Powered by patients. We collect data and help patients today and tomorrow. OurBrainBank is the first non-profit created by, with, and for people living with glioblastoma. GBM is a rare and aggressive brain cancer. The 5-year survival rate is 5%. OBB founder Jessica Morris (1963-2021) was diagnosed with GBM in 2016. Frustrated by the paucity of options, she brought together fellow patients, neuro-oncologists, and tech experts to form OBB. Our pilot study used a free app to help people manage GBM better by tracking symptoms and activities. Were now developing a new data collection program using passive data collected by everyday smartphone usage. Patient-driven data is the new currency in medical research and apps the new empowerment tool for patients. It could potentially have the same impact as a blockbuster new drug. OurBrainBank advocates for new and better treatments and improved quality of life for people living with GBM and their care partners. A key tool is our GBM Bill of Rights.

Consulting & advisory services to innovative life sciences firms commercializing assets in the US | Oncology Diagnostics | Sales | Marketing | Market Access & Reimbursement | Business Development | Communications | Client Services | Revenue Cycle Management | Investor Relations | Fund-Raising | Board Member & Advisor